Neuronetics Showcases Real-World TMS Data at CTMSS 2026
Event summary
- Neuronetics presented real-world TMS data at CTMSS 2026, including findings on age, sex, and adolescent outcomes.
- The company sponsored the event as a Silver Sponsor and participated in the PULSES Course.
- Presentations included oral and poster sessions on TMS effectiveness and maintenance therapy.
- Neuronetics highlighted its TrakStar database as the largest real-world TMS database.
The big picture
Neuronetics' focus on real-world TMS data aligns with broader industry trends toward evidence-based mental health treatments. The company's leadership in TMS therapy positions it to capitalize on growing demand for non-drug solutions. Its strategic partnerships, such as with ANT Neuro, further strengthen its competitive edge in the neuroscience sector.
What we're watching
- Data Utilization
- How Neuronetics leverages real-world evidence to drive TMS adoption and differentiation.
- Market Expansion
- Whether the company can sustain growth in adolescent TMS therapy.
- Competitive Positioning
- The pace at which Neuronetics integrates new partnerships to enhance TMS technology.